Efficacy and safety of upadacitinib, a selective JAK-1 inhibitor in treatment of ankylosing spondylitis: a meta-analysis
Through a literature analysis, it reveals that UPA offers significant therapeutic benefits to AS patients with a relatively high safety profile.
Authors
- Xueting Yang (ORCID: https://orcid.org/0000-0003-4633-2185)
- Qi Yao (ORCID: https://orcid.org/0000-0002-3786-2814)
- Yanfang Pu
- Yixuan Zhu
- Yanling Ma (ORCID: https://orcid.org/0000-0001-9025-1804)
- Zhiqing Zhang
Institutions
- Kunming University of Science and Technology (CN)
- Kunming Medical University (CN)
- First People's Hospital of Yunnan Province (CN)
- First Affiliated Hospital of Kunming Medical University (CN)
- Dali University (CN)
Publication Details
- Journal
- BMC Rheumatology
- Published
- 2025-02-18
- DOI
- https://doi.org/10.1186/s41927-025-00467-1
- Citations
- 4
- Primary Topic
- Spondyloarthritis Studies and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 6.67